Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on May 11, 2020. The filing serves to announce the Company's financial results for the quarter ended March 31, 2020. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2, respectively.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended March 31, 2020.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company explicitly states it does not assume any obligation to update the information contained in the press release or letter to stockholders in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2020 revenue and earnings figures.
- Review Exhibit 99.2 (Letter to Stockholders) for management commentary on operational performance and liquidity.
- Verify the Company's cash position and burn rate given the Q1 2020 reporting period.
- Confirm if the Company has updated its forward-looking guidance in the attached exhibits.